DLEU7
Leukemia-associated protein 7
Also known as: FLJ44882, LEU7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UYE1
- Gene
- DLEU7
- Ensembl
- ENSG00000186047
- Chromosome
- 13
- Canonical length
- 221 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for DLEU7 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
221 residues, UniProt reviewed canonical sequence.
>Q6UYE1|DLEU7
1 MASPAPLVAS ISHQMVALQT LQLLQQEWGW GDGPVAPGNP RDPDHVSTAP ARRSGPPRAR
61 PGPGREERGG GVGTRSRRTA ARANSPEEEV VRGAEGGAEL LPFPRDRGPC TLAQMAMRSA
121 LARVVDSTSE LVSVEQTLLG PLQQERSFPI HLKDSVEFRN ICSHLALQIE GQQFDRDLNA
181 AHQCLKTIVK KLIQSLANFP SDAHMVACAS LRQILQNLPD ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against DLEU7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 5.2 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 5.2 nTPM
- cerebellum: 3.8 nTPM
- hypothalamus: 3.5 nTPM
- basal ganglia: 3.2 nTPM
- amygdala: 3 nTPM
- hippocampal formation: 2.8 nTPM
Single-cell type
- microglia: 277 nCPM
- kupffer cells: 98 nCPM
- brain inhibitory neurons: 57 nCPM
- oligodendrocyte progenitor cells: 47 nCPM
- early spermatids: 46 nCPM
- brain excitatory neurons: 41 nCPM
Immune cell
- intermediate monocyte: 0.2 nTPM
- neutrophil: 0.2 nTPM
- T-reg: 0.2 nTPM
- total PBMC: 0.2 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- white matter: 7 nTPM
- thalamus: 6.9 nTPM
- cerebral cortex: 5.7 nTPM
- midbrain: 5.7 nTPM
- basal ganglia: 5.4 nTPM
- medulla oblongata: 5.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.6
- gnomAD pLI
- 0.18
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Leukemia-associated protein 7
- Leukemia-associated protein 7
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DLEU7 as an antibody target. Whether an autoantibody or antibody against DLEU7 could matter depends on whether native DLEU7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DLEU7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DLEU7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...